Profil
Joris Winderickx is the founder of reMYND NV, where he currently serves as the Scientific Advisor since 2012.
He founded the company in 2002.
Dr. Winderickx is also the founder of Royal Flemish Chemical Society.
Dr. Winderickx's former job includes being a Director at ADx NeuroSciences NV.
Additionally, he worked as a Professor at Katholieke Universiteit Leuven.
Dr. Winderickx's education includes a doctorate degree from Katholieke Universiteit Leuven.
Aktive Positionen von Joris Winderickx
| Unternehmen | Position | Beginn |
|---|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Corporate Officer/Principal | 30.05.2012 |
Ehemalige bekannte Positionen von Joris Winderickx
| Unternehmen | Position | Ende |
|---|---|---|
Royal Flemish Chemical Society | Gründer | - |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology Develops diagnostic antibodies for neurodegenerative diseases through research | Direktor/Vorstandsmitglied | - |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Joris Winderickx
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology Develops diagnostic antibodies for neurodegenerative diseases through research | Health Technology |
Royal Flemish Chemical Society |
















